⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20657063 | 0.69 | — | — | |
| SCHEMBL1622357 | 0.69 | — | — | |
| SCHEMBL27572275 | 0.64 | — | — | |
| SCHEMBL475003 | 0.64 | — | — | |
| SCHEMBL9148585 | 0.63 | — | — | |
| SCHEMBL29090360 | 0.62 | — | — | |
| SCHEMBL1931721 | 0.59 | APLNR (0.35) | — | |
| SCHEMBL707678 | 0.59 | — | — | |
| SCHEMBL60402 | 0.59 | — | — | |
| SCHEMBL124081 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 365 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2755983-B1 | SUBSTITUTED CARBONYLOXYMETHYLPHOSPHORAMIDATE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF VIRAL INFECTIONS | IDENIX PHARMACEUTICALS LLC (US) | 2017-03-15 | — | — | EP | claimed |
| US-9403863-B2 | Substituted carbonyloxymethylphosphoramidate compounds and pharmaceutical compositions for the treatment of viral infections | IDENIX PHARMACEUTICALS LLC (US) | 2016-08-02 | — | — | US | claimed |
| EP-1488846-B1 | Composite semipermeable membrane, and production process thereof | TORAY INDUSTRIES (JP) | 2013-03-13 | — | — | EP | claimed |
| WO-2024145662-A1 | 2-SUBSTITUTED THIAZOLE AND BENZOTHIAZOLE COMPOSITIONS AND METHODS AS DUX4 INHIBITORS | ALTAY THERAPEUTICS, INC. (US) | 2024-07-04 | — | — | WO | disclosed |
| WO-2024112705-A1 | BORONIC ACID AND BORONATE COMPOSITIONS AND METHODS | ELIMA THERAPEUTICS, INC. (US) | 2024-05-30 | — | — | WO | disclosed |
| US-20240101562-A1 | NOVEL COMPOUND, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING RESISTANT CANCER, COMPRISING SAME | HOLOSMEDIC (KR) | 2024-03-28 | — | — | US | disclosed |
| US-11866515-B2 | Hemiasterlin derivatives for conjugation and therapy | SUTRO BIOPHARMA, INC. (US) | 2024-01-09 | — | — | US | disclosed |
| EP-3131914-B1 | 3'-SUBSTITUTED METHYL OR ALKYNYL NUCLEOSIDES FOR THE TREATMENT OF HCV | IDENIX PHARMACEUTICALS LLC (US) | 2023-05-10 | — | — | EP | disclosed |
| US-20230139442-A1 | MODIFIED AMINO ACIDS | SUTRO BIOPHARMA, INC. | 2023-05-04 | — | — | US | disclosed |
| EP-4174068-A1 | NOVEL COMPOUND, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING RESISTANT CANCER, COMPRISING SAME | Holosmedic (KR) | 2023-05-03 | — | — | EP | disclosed |
| CN-115916206-A | Novel compound and pharmaceutical composition for preventing or treating resistant cancer comprising same | 治愈医药社株式会社 | 2023-04-04 | — | — | CN | disclosed |
| WO-2004002422-A2 | 2’-C-METHYL-3’-O-L-VALINE ESTER RIBOFURANOSYL CYTIDINE FOR TREATMENT OF FLAVIVIRIDAE INFECTIONS | IDENIX (CAYMAN) LIMITED (KY) | 2004-01-08 | — | — | WO | disclosed |
| US-6667306-B1 | Aminobenzothiazole and aminobenzoxazole derivatives; thrombosis | MILLENNIUM PHARMACEUTICALS, INC. | 2003-12-23 | — | — | US | disclosed |
| CN-1340162-A | Methods and kits for sequencing polypeptides | PROCTER & GAMBLE (US) | 2002-03-13 | — | — | CN | disclosed |
| EP-1145012-A2 | METHODS AND KITS FOR SEQUENCING POLYPEPTIDES | The Procter & Gamble Company (US) | 2001-10-17 | — | — | EP | disclosed |
| EP-1047699-A1 | PLATELET ADP RECEPTOR INHIBITORS | COR THERAPEUTICS, INC. (US) | 2000-11-02 | — | — | EP | disclosed |
| WO-2000043792-A2 | METHODS AND KITS FOR SEQUENCING POLYPEPTIDES | THE PROCTER & GAMBLE COMPANY (US) | 2000-07-27 | — | — | WO | disclosed |
| WO-1999036425-A1 | PLATELET ADP RECEPTOR INHIBITORS | COR THERAPEUTICS, INC. (US) | 1999-07-22 | — | — | WO | disclosed |
| US-4913988-A | IMPROVED PERFORMANCE OF MANGANESE DI OXIDE CATHODE AT LOW TEMPERATURE | EVEREADY BATTERY COMPANY, INC. (US) | 1990-04-03 | — | — | US | disclosed |
| EP-0068492-A1 | Non-aqueous cell having a solid cathode comprising a lead fluoride/tin fluoride compound | UNION CARBIDE CORPORATION (US) | 1983-01-05 | — | — | EP | disclosed |